Robert L. Suddith
9Patents
8h-index
17Co-inventors
62Inventor score
Filing activity: Sep 24, 1986 → Dec 24, 1997
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6024938A | Lyophilized imaging agent formulation comprising a chemotactic peptide | Human Necessities | 97 | Expired |
| US4861580A | Composition using salt form of organic acid derivative of alpha-tocopheral | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5262168A | Prostaglandin-lipid formulations | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5082664A | Prostaglandin-lipid formulations | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5556580A | Liposome continuous size reduction method and apparatus | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5925375A | Therapeutic use of multilamellar liposomal prostaglandin formulations | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5330689A | Entrapment of water-insoluble compound in alpha tocopherol-based vesicles | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5783210A | Phospholipid composition | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5429823A | Phospholipid composition and liposomes made therefrom | Emerging Cross-Sectional Technologies | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.